Résultats de la recherche
10
Tout
Rechercher les filtres
Mot-clé
#healthcare
MODV Shareholders Have an Opportunity to Lead the Class Action Against ModivCare, Inc. – Contact Shareholder Rights Law Firm Robbins LLP for Information
11 mars 2025 18h01 HE
|
Robbins LLP
Robbins LLP is Investigating Allegations that ModivCare, Inc. (MODV) Misled Investors Regarding its Business Prospects
Alvogen Completes Comprehensive Refinancing with Longer-Dated Maturity Profile and Reduction of Debt
10 mars 2025 03h00 HE
|
Aztiq Consulting ehf.
REYKJAVIK, Iceland and MORRISTOWN, N.J., March 10, 2025 (GLOBE NEWSWIRE) -- Alvogen Pharma US, Inc. (“Alvogen” or the “Company”), a privately owned US-based pharmaceutical company, has completed a...
EDAP to Announce Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025
06 mars 2025 07h00 HE
|
EDAP TMS S.A.
Company to host conference call and webcast on Thursday, March 27th at 8:30am EDT AUSTIN, Texas, March 6, 2025 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based...
EDAP Appoints Glen French to Board of Directors
03 mars 2025 07h00 HE
|
EDAP TMS S.A.
PDF Version LYON, France, March 3, 2025 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company” or “EDAP”), the global leader in robotic energy-based therapies, today announced the appointment of Glen French to...
Texas State University Continuing Education and MedCerts, a Stride, Inc. Company, Partner to Expand Access to Healthcare Training Programs
27 févr. 2025 09h00 HE
|
MedCerts
San Marcos, TX, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Texas State University’s Continuing Education Office and MedCerts, a nationally recognized leader in online healthcare training, are excited to...
Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.
21 févr. 2025 06h00 HE
|
Alvotech
In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™ for all indications matching the reference product Stelara® (ustekinumab) and has granted a provisional determination of...
Cortechs.ai and EDAP Announce World’s First OnQ™ Prostate-Assisted Focal One® Robotic HIFU Procedure at UCSF Prostate Cancer Center
06 févr. 2025 08h00 HE
|
EDAP TMS S.A.
First Focal One® procedure utilizing Cortechs.ai’s advanced MRI-imaging technology, OnQ Prostate, successfully performed at the University of California, San Francisco Prostate Cancer CenterOnQ...
Definitive Healthcare named a 2025 Best Places to Work in Boston by Built In
29 janv. 2025 09h46 HE
|
Definitive Healthcare Corp.
FRAMINGHAM, Mass., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it has been named one of Built...
SAB BIO Announces Positive Topline Phase 1 Clinical Results with Potentially Disease-Modifying T1D Therapy SAB-142
28 janv. 2025 07h00 HE
|
SAB Biotherapeutics, Inc.
SAB BIO Announces Positive Topline Phase 1 Clinical Results with Potentially Disease-Modifying T1D Therapy SAB-142
MedCerts and FocusQuest Join Forces to Expand Opportunities for Minority Students in Allied Health and IT Careers
21 janv. 2025 14h53 HE
|
MedCerts
LANHAM, Md., Jan. 21, 2025 (GLOBE NEWSWIRE) -- MedCerts, a nationally recognized leader in online healthcare and IT career training, and FocusQuest LLC, a passionate advocate for student success and...